Literature DB >> 17457369

Genotypic and haplotypic associations of the DBH gene with plasma dopamine beta-hydroxylase activity in African Americans.

Yi-lang Tang1, Michael P Epstein, George M Anderson, Cyrus P Zabetian, Joseph F Cubells.   

Abstract

Several variants at DBH are significantly associated with plasma DbetaH activity (pDbetaH). However, the overwhelming majority of data on this genotype-phenotype relationship has been gathered in samples from Europeans and European Americans (EAs). In this study, we examined the relationship between DBH polymorphisms and pDbetaH in samples from African-American (AA) subjects. Genotypes were determined at a 19-bp insertion/deletion polymorphism (ins/del) and four single-nucleotide polymorphisms (SNPs) at DBH in 109 samples. Analyses were performed using analyses of variance (ANOVAs) (for individual SNPs) and regression procedures (to assess the joint effects and the specific SNP-based haplotypes). We found: (1) single-variant analysis of all polymorphisms revealed apparent associations to pDbetaH, with rs1611115 accounting for the largest proportion of the variance in pDbetaH (28.7%) and ins/del the smallest (6.5%); (2) modest but significant linkage disequilibrium (LD) existed between ins/del and rs1611115; (3) LD between all other pairs of variants was not observed; (3) stepwise regression showed that a model containing rs1611115, rs2519152 and rs6271 accounted for 37.6% of the variance in pDbetaH, with rs6271 showing additional 7.6% above the effect of rs1611115, and rs2519152 showing additional 2% above rs1611115 and rs6271; (4) two common haplotypes, C-T-C and T-C-C at rs1611115-rs2519152-rs6271 were significantly associated with pDbetaH (P=0.0025 and 0.0036, respectively). The data support the validity of prior reported associations and underscore the importance of analyzing multiple SNPs across DBH in future association studies examining disease and biochemical phenotypes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457369     DOI: 10.1038/sj.ejhg.5201838

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  21 in total

Review 1.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

2.  Characterization of SNPs in the dopamine-β-hydroxylase gene providing new insights into its structure-function relationship.

Authors:  Toyanji Joseph Punchaichira; Sanjay Kumar Dey; Anirban Mukhopadhyay; Suman Kundu; B K Thelma
Journal:  Neurogenetics       Date:  2017-07-13       Impact factor: 2.660

3.  The catecholamine biosynthetic enzyme dopamine β-hydroxylase (DBH): first genome-wide search positions trait-determining variants acting additively in the proximal promoter.

Authors:  Maja Mustapic; Adam X Maihofer; Manjula Mahata; Yuqing Chen; Dewleen G Baker; Daniel T O'Connor; Caroline M Nievergelt
Journal:  Hum Mol Genet       Date:  2014-06-30       Impact factor: 6.150

4.  Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia.

Authors:  Li Hui; Mei Han; Xu Feng Huang; Min Jie Ye; Ke Zheng; Jin Cai He; Meng Han Lv; Bao Hua Zhang; Jair C Soares; Xiang Yang Zhang
Journal:  J Neural Transm (Vienna)       Date:  2014-10-22       Impact factor: 3.575

5.  Genotype-controlled analysis of serum dopamine β-hydroxylase activity in civilian post-traumatic stress disorder.

Authors:  Yi-lang Tang; Wenbiao Li; Kristina Mercer; Bekh Bradley; Charles F Gillespie; Robert Bonsall; Kerry J Ressler; Joseph F Cubells
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-08-22       Impact factor: 5.067

6.  The effects of DBH, MAOA, and MAOB on attentional biases for facial expressions.

Authors:  Pingyuan Gong; Shoumin Xi; Guomin Shen; She Li; Peizhe Zhang; Guochang Cao; Fuchang Zhang; Yan Shen; Tiantian Feng; Hua Ma
Journal:  J Mol Neurosci       Date:  2012-10-05       Impact factor: 3.444

7.  Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.

Authors:  Maja Mustapic; Paola Presecki; Nela Pivac; Ninoslav Mimica; Patrick R Hof; Goran Simic; Vera Folnegovic-Smalc; Dorotea Muck-Seler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-02-13       Impact factor: 5.067

8.  Pharmacogenetics of Dopamine β-Hydroxylase in cocaine dependence therapy with doxazosin.

Authors:  Xuefeng Zhang; David A Nielsen; Coreen B Domingo; Daryl I Shorter; Ellen M Nielsen; Thomas R Kosten
Journal:  Addict Biol       Date:  2018-03-02       Impact factor: 4.280

9.  Association between migraine and a functional polymorphism at the dopamine beta-hydroxylase locus.

Authors:  F Fernandez; N Colson; S Quinlan; J MacMillan; R A Lea; L R Griffiths
Journal:  Neurogenetics       Date:  2009-02-14       Impact factor: 2.660

10.  The C-1021T polymorphism of dopamine β-hydroxylase is not associated with orthostatic hypotension in a Chinese population.

Authors:  N Lu; J Chen; Y Yuan; X Cong; Y Yang; L Meng; K Sun; R Hui; Y Zheng
Journal:  J Hum Hypertens       Date:  2014-07-03       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.